111 related articles for article (PubMed ID: 2291993)
1. Density-gradient separation of autologous bone marrow grafts before ex vivo purging with 4-hydroperoxycyclophosphamide.
Rowley SD; Davis JM; Piantadosi S; Jones RJ; Yeager AM; Santos GW
Bone Marrow Transplant; 1990 Nov; 6(5):321-7. PubMed ID: 2291993
[TBL] [Abstract][Full Text] [Related]
2. Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts.
Rowley S; Davis J; Braine H; Jones R; Yeager A; Saral R; Santos G
Prog Clin Biol Res; 1990; 333():369-77. PubMed ID: 2308991
[TBL] [Abstract][Full Text] [Related]
3. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
4. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
5. Density gradient separation of hematopoietic stem cells in autologous bone marrow transplantation.
Iacone A; Quaglietta AM; D'Antonio D; Accorsi P; Dragani A; Angrilli F; Berardi A; Angelini A; Di Bartolomeo P; Di Bartolomeo G
Haematologica; 1991 Mar; 76 Suppl 1():18-21. PubMed ID: 1677910
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
Lemoli RM; Strife A; Clarkson BD; Haley JD; Gulati SC
Exp Hematol; 1992 Dec; 20(11):1252-6. PubMed ID: 1493854
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557).
Douay L; Mary JY; Giarratana MC; Najman A; Gorin NC
Exp Hematol; 1989 Jun; 17(5):429-32. PubMed ID: 2653856
[TBL] [Abstract][Full Text] [Related]
8. Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30.
Humblet Y; Lefebvre P; Jacques JL; Bosly A; Feyens AM; Sekhavat M; Agaliotis D; Symann M
Bone Marrow Transplant; 1988 Jan; 3(1):63-7. PubMed ID: 2901880
[TBL] [Abstract][Full Text] [Related]
9. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
10. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
Shpall EJ; Jones RB; Bast RC; Rosner GL; Vandermark R; Ross M; Affronti ML; Johnston C; Eggleston S; Tepperburg M
J Clin Oncol; 1991 Jan; 9(1):85-93. PubMed ID: 1985173
[TBL] [Abstract][Full Text] [Related]
11. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
Rowley SD; Piantadosi S; Santos GW
Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
Domenech J; Desbois I; Linassier C; Gihana E; Chenault S; Brémond JL; Colombat P; Lamagnère JP; Binet C
Bone Marrow Transplant; 1993 Jun; 11(6):425-31. PubMed ID: 8334422
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
Rowley SD; Jones RJ; Piantadosi S; Braine HG; Colvin OM; Davis J; Saral R; Sharkis S; Wingard J; Yeager AM
Blood; 1989 Jul; 74(1):501-6. PubMed ID: 2665843
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedure.
Pierelli L; Menichella G; Serafini R; de Martini M; Paoloni A; Foddai ML; Scambia G; Benedetti Panici PL; Mancuso S; Leone G
Bone Marrow Transplant; 1991 May; 7(5):355-61. PubMed ID: 2070144
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
16. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.
Rowley SD; Zuehlsdorf M; Braine HG; Colvin OM; Davis J; Jones RJ; Saral R; Sensenbrenner LL; Yeager A; Santos GW
Blood; 1987 Jul; 70(1):271-5. PubMed ID: 3297203
[TBL] [Abstract][Full Text] [Related]
17. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
Giarratana MC; Gorin NC; Douay L
Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
[TBL] [Abstract][Full Text] [Related]
18. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of combination drug purging for autologous bone marrow transplantation.
Rowley SD; Miller CB; Piantadosi S; Davis JM; Santos GW; Jones RJ
J Clin Oncol; 1991 Dec; 9(12):2210-8. PubMed ID: 1960561
[TBL] [Abstract][Full Text] [Related]
20. Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide.
Rowley SD; Colvin OM; Stuart RK
Exp Hematol; 1985 May; 13(4):295-8. PubMed ID: 3987832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
